Mastectomy Clinical Trials

A listing of Mastectomy medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 203 clinical trials
  • 0 views
  • 22 Jan, 2021
  • 2 locations
Postmastecomy Internal Mammary Nodal Irradiation for High-risk Breast Cancer Patients

The purpose of this study is to evaluate the impact of internal mammary nodal irradiation on disease-free survival in high-risk breast cancer patients treated with mastectomy.

hormone therapy
mastectomy
metastasis
taxane
anthracyclines
  • 0 views
  • 28 Aug, 2021
  • 1 location
Hypofractionated LocoRegional Radiotherapy in Breast Cancer

breast conserving surgery (BCS), or to the chest wall and regional nodes following mastectomy, is non-inferior to conventional fractionation delivered over 3 weeks in patients with node positive breast

invasive carcinoma
cancer
carcinoma
breast-conserving surgery
mastectomy
  • 0 views
  • 15 Sep, 2021
  • 8 locations
HYPofractionated Adjuvant RadioTherapy in 1 Versus 2 Weeks in High-risk Patients With Breast Cancer (HYPART).

mastectomy and 40Gy/16/3wks after breast conserving surgery (BCS).It is also a routine practice in the UK and in a few centers in Canada. Hypofractionation reduces treatment time to half while

invasive carcinoma
breast-conserving surgery
carcinoma
mastectomy
hormone therapy
  • 0 views
  • 01 Jul, 2021
  • 1 location
Management of Low-risk (Grade I and II) DCIS

treatment, being either WLE alone, WLE + RT, or mastectomy, and possibly HT, should remain the standard of care.

estrogen
mammogram
mastectomy
hormone therapy
breast cancer
  • 410 views
  • 17 Feb, 2021
  • 45 locations
Hypofractionated Irradiation At Regional Nodal Area for Breast Cancer Vs Existed Standard Treatment

intensity-modulated radiation therapy (IMRT) in breast cancer patients with an indication for regional nodal irradiation (RNI) following mastectomy or breast conserving surgery. Patients will be randomized

progesterone
breast-conserving surgery
estrogen
epidermal growth factor
mastectomy
  • 0 views
  • 28 Jun, 2021
  • 1 location
Evaluation of Tamoxifen's Efficacy for ER/PR Negative ER-beta Positive Operable Breast Cancer Patients

-(wild type ER-1) positive operable breast cancer patients who had undergone neoadjuvant chemotherapy or directly modified radical mastectomy or breast-conserving surgery were randomly (1:1) enrolled to

sentinel lymph node biopsy
breast-conserving surgery
mammogram
adjuvant therapy
mastectomy
  • 30 views
  • 03 Feb, 2021
  • 17 locations
POSNOC - A Trial Looking at Axillary Treatment in Early Breast Cancer

surgery (BCS) or mastectomy, Estrogen receptor (ER) status (positive, negative), Number of positive nodes (1, 2), Intra-operative sentinel assessment using OSNA (yes, no). Interventions The study

sentinel lymph node biopsy
sentinel node
breast cancer staging
erbb2
growth factor
  • 1778 views
  • 04 Jul, 2021
  • 50 locations
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery

This randomized phase III trial studies standard or comprehensive radiation therapy in treating patients with early-stage breast cancer who have undergone surgery. Radiation therapy uses high-energy x rays to kill tumor cells. It is not yet known whether comprehensive radiation therapy is more effective than standard radiation therapy in treating …

progesterone
invasive carcinoma
sentinel lymph node biopsy
ductal carcinoma in situ
human epidermal growth factor
  • 784 views
  • 24 Jan, 2021
  • 127 locations
Comparing an Operation to Monitoring With or Without Endocrine Therapy (COMET) Trial For Low Risk DCIS

This study looks at the risks and benefits of active monitoring (AM) compared to surgery in the setting of a pragmatic prospective randomized trial for low risk DCIS. Our overarching hypothesis is that management of low-risk Ductal Carcinoma in Situ (DCIS) using an AM approach does not yield inferior cancer …

mammogram
carcinoma in situ
mastectomy
hormone therapy
breast cancer
  • 1212 views
  • 03 Sep, 2021
  • 137 locations